Home » Authors » Holland Johnson

Articles by Holland Johnson

Cyberonics' therapy deemed approvable for depression use

Feb. 4, 2005

By Holland Johnson

Clearance for AxiaLIF brings TranS1 to financial crossroads

Feb. 2, 2005

By Holland Johnson

In a tale of two HIFUs, firms note progress in efforts to address AF

Feb. 1, 2005

By Holland Johnson

NovoSci touts 'mini' bypass as potential new standard-of-care

Jan. 31, 2005

By Holland Johnson

Ariad, Medinol partnering to develop DES, other devices

Jan. 28, 2005

By Holland Johnson

Abbott set to initiate 'landmark' carotid stent trial in the U.S.

Jan. 26, 2005

By Holland Johnson

SCD-HeFT results pave way for expanded ICD population

Jan. 21, 2005

By Holland Johnson

Diagnosis: Growth for firms providing testing products

Jan. 20, 2005

By Holland Johnson

JP Morgan Healthcare Conference: Diagnostic imaging seen as excellent sector for investors

Jan. 20, 2005

By Holland Johnson

JP Morgan Healthcare Conference: Diagnosis: Growth for firms providing testing products

Jan. 18, 2005

By Holland Johnson

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...